Moirai Biodesign’s General Shareholders Meeting is suspended due to agenda issues. Please find the official communication here.
More
Founded on the combination of cutting-edge synthetic biology and computational biology, Moirai Biodesign is putting RNA design at the service of biomedicine.
We envision our technologies and expertise as the catalysts of a healthcare ecosystem where rapid and affordable diagnostic methods are an option for all patients worldwide.
Amadís Pagès
Co-Founder and CEO
Ivan Dotu
Co-founder and CTO
Daniel Poglayen
Co-founder and CPDO
Cristina Alsina
Research Scientist
Judit Domingo
Product Developer
Gerard Minuesa
Research Scientist
Moirai Biodesign’s General Shareholders Meeting will be held on June, 27th, at 10:00h. Please find the agenda here.
More
Moirai Biodesign’s General Shareholders Meeting will be held on June, 28th, at 10:30h. Please find the agenda here.
More
The dawn of an era in the biotech industry It was back in 1953 when the elucidation of the DNA structure by Dr. James D. Watson and Dr. Francis Crick,
More
Moirai Biodesign’s General Shareholders Meeting will be held on October, 5th, at 10:00h. Please find the agenda here.
More